Macular Degeneration Treatment Market Share 2022, Growth, Report, Analysis 2027

According to the latest report by IMARC Group, titled “Macular Degeneration Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” offers a comprehensive analysis of the industry, which comprises insights on the global macular degeneration treatment market share. The report also includes competitor and regional analysis, and contemporary advancements in the market.

The global macular degeneration treatment market size reached a value of US$ 8.33 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 12.5 Billion by 2027 exhibiting a CAGR of 6.70% during 2022-2027.

Macular degeneration is to a neurodegenerative ocular disorder that causes retinal damage and a blurred or complete loss of vision in the center of the visual field. Some commonly used treatment methods for macular degeneration are anti-angiogenic medications, contact lenses, transitional lenses, and photodynamic laser therapies. It is characterized by visual distortion, blind spots in the field of vision, and the inability to see in poor lighting. In recent years, macular generation treatment has gained immense popularity across the globe as it can improve vision and reduce the chances of developing chronic blindness.

Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/macular-degeneration-treatment-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Macular Degeneration Treatment Market Trends and Drivers:

The global macular degeneration treatment market is primarily driven by the increasing prevalence of retinal disorders and the expanding geriatric population that is more susceptible to developing age-related macular degeneration. Additionally, prolonged screen time due to the rising usage of cell phones, laptops, and television is contributing to the development of the macular generation, which has augmented the demand for its treatment.

Moreover, several key players are extensively investing in research and development (R&D) activities to launch innovative and effective drugs. In line with this, the introduction of retinal gene therapies that involve injecting adeno-associated virus (AAV) into the body to prevent abnormal blood vessel growth is positively influencing the market growth.

Other factors, including the escalating demand for biosimilar drugs, favorable government initiatives promoting public health, and improving healthcare infrastructure, are also anticipated to propel market growth.

Global Macular Degeneration Treatment Market 2022-2027 Analysis and Segmentation:

 Competitive Landscape:

 The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Aerie Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Iveric Bio Inc., Novartis AG, Panoptica, Pfizer Inc., Phio Pharmaceuticals, Regeneron Pharmaceuticals Inc., Regenxbio Inc. and Santen Pharmaceutical Co. Ltd.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=5118&flag=C

The report has segmented the market on the basis of region, type, stage of disease, route of administration and end user.

Breakup by Type:

  • Dry Age-related Macular Degeneration
  • Wet Age-related Macular Degeneration

Breakup by Stage of Disease:

  • Early Stage
  • Intermediate Stage
  • Late Stage

Breakup by Route of Administration:

  • Intravenous Route
  • Intravitreal Route

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Center
  • Others

Breakup by Region:

  • North America: (United States, Canada)
  • Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America: (Brazil, Mexico, Others)
  • Middle East and Africa

 If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022- 2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Leave a Reply

Your email address will not be published. Required fields are marked *

WC Captcha 43 + = fifty one